01/30/2020

How IVI is confronting schistosomiasis in Madagascar

As we globally recognize the first ever World Neglected Tropical Diseases Day, we take this opportunity to specifically raise awareness around Schistosomiasis, a devastating Neglected Tropical Disease (NTD) endemic in 78 low- and middle-income countries.   What is schistosomiasis? Schistosomiasis is a poverty-associated disease caused […]
05/26/2020

Present & Future of Vaccine Development seminar series: The architecture of SARS-CoV-2 genome with Prof. V. Narry Kim

May 22, 2020, SEOUL, South Korea — For our first lecture in our ‘Present and Future of Vaccine Development’ series of 2020, we welcomed Professor V. Narry Kim from Seoul National University to present on the SARS-CoV-2 (the virus causing COVID-19) genome and its transcriptomic architecture. […]
06/09/2020

IVI Fact-Checks: COVID-19

There is an abundance of resources online and elsewhere related to COVID-19, and it’s important to stay informed on the latest and most accurate facts. Refer to your local and national authorities on the most up-to-date recommendations and restrictions, and touch base with the WHO’s Advice […]
06/11/2020

Genexine consortium’s Covid-19 vaccine acquires approval for clinical trails in Korea

Originally published in Dong-A Science June 11, 2020   The new candidate COVID-19 vaccine ‘GX-1,’ which is being developed by the Korean biotech company Genexine, has been approved for phase 1 and 2a clinical trials in South Korea. It is the first time that a […]